<DOC>
	<DOCNO>NCT00122863</DOCNO>
	<brief_summary>This clinical trial assess time relapse anxiety symptom among patient generalize anxiety disorder respond duloxetine therapy .</brief_summary>
	<brief_title>Duloxetine Compared With Placebo Prevention Relapse Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Patients present generalized anxiety disorder ( GAD ) absence major depressive disorder ( MDD ) . Patients must suffer GAD adjustment disorder anxiety disorder otherwise specify ( NOS ) . Symptoms GAD situational nature . Any current primary diagnosis GAD . Patients diagnose history MDD within past 6 month OR patient diagnosed history panic disorder , posttraumatic stress disorder ( PTSD ) , eat disorder within past year OR patient diagnose obsessive compulsive disorder ( OCD ) , bipolar affective disorder , psychosis , factitious disorder somatoform disorder lifetime . History alcohol psychoactive substance abuse dependence ( defined DSMIVTR ) within past 6 month Serious medical illness , include cardiovascular , hepatic , renal , respiratory , hematologic , endocrinologic , neurologic disease , clinically significant laboratory abnormality stabilize anticipated require hospitalization within 6 month , opinion investigator . Clinically significant laboratory abnormality , , judgement investigator , indicate serious medical problem . Acute liver injury ( hepatitis ) severe cirrhosis ( Child Pugh Class C )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>